THE REMY Trademark

Trademark Overview


On Tuesday, August 13, 2024, a trademark application was filed for THE REMY with the United States Patent and Trademark Office. The USPTO has given the THE REMY trademark a serial number of 98696237. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Wednesday, February 26, 2025. This trademark is owned by Zoom Láser International LLC. The THE REMY trademark is filed in the Medical Instrument Products category with the following description:

Lasers for surgical and medical use in the fields of podiatry and pain management
the remy

General Information


Serial Number98696237
Word MarkTHE REMY
Filing DateTuesday, August 13, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateWednesday, February 26, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesLasers for surgical and medical use in the fields of podiatry and pain management

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateTuesday, August 13, 2024
Primary Code010
First Use Anywhere DateWednesday, February 28, 2018
First Use In Commerce DateWednesday, February 28, 2018

Trademark Owner History


Party NameZoom Láser International LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressCherry Hill, NJ 08003

Trademark Events


Event DateEvent Description
Tuesday, August 13, 2024NEW APPLICATION ENTERED
Thursday, January 16, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, February 19, 2025ASSIGNED TO EXAMINER
Wednesday, February 26, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, February 26, 2025NON-FINAL ACTION E-MAILED
Wednesday, February 26, 2025NON-FINAL ACTION WRITTEN